Category: Disclosures

[Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release (Information Disclosure) / 2024-10-17

December 17, 2024August 4, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Daeduck Electronics has announced in advance that it plans to disclose its provisional Q3 2024 financial results on October 31, 2024. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Earnings Release Disclosure and Final Confirmed Figures Through this…

Semiconductors, Disclosures

[Disclosure] Hanwha Systems (272210) – Decision on Capital Increase / 2024-12-17

December 17, 2024August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems’ U.S. subsidiary (HS USA Holdings Corp.) has decided on a rights offering worth approximately KRW 91.8B to fund the acquisition of securities in another corporation and operating expenses. 📊 [Key Disclosure Details & Financial Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Execution of…

Disclosures, Defense

[Disclosure] Hanwha Systems (272210) – Decision on Acquisition of Shares and Equity Securities of Other Corporation (Correction) / 2024-12-17

December 17, 2024August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems has finalized the scheduled acquisition date (payment date) for shares in its U.S. subsidiary (HS USA HOLDINGS CORP.) as December 17, 2024, and disclosed corrected details including the KRW-equivalent amount. 📊 [Key Disclosure Details & Financial Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Disclosures, Defense

[Disclosure] Daeduck Electronics (353200) – Other Management Matters (Voluntary Disclosure) (Notice Regarding Dividend Record Date) / 2024-12-17

December 17, 2024August 4, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Daeduck Electronics announced that to adopt an advanced dividend procedure, its FY2024 year-end dividend record date will be set by a Board resolution in Q1 2025, rather than automatically on December 31. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Semiconductors, Disclosures

[Disclosure] Daeduck Electronics (353200) – (Correction) New Facility Investment / 2024-12-17

December 17, 2024August 4, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Daeduck Electronics has extended the completion date for its KRW 270 billion FCBGA production facility investment by three years, moving the deadline from December 31, 2024, to December 31, 2027, due to increased market demand volatility. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment…

Disclosures, Semiconductors

[Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2024-12-17

December 17, 2024August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued a correction disclosure regarding its pharmaceutical contract manufacturing agreement with Checkpoint Therapeutics, Inc., moving forward the contract end date from October 2, 2030, to December 17, 2024, following the completion of contract performance. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract / 2024-12-17

December 17, 2024August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed the signing of a pharmaceutical contract manufacturing agreement with a US-based pharmaceutical company valued at approx. KRW 111.3B (USD 77,544,000), representing 3.01% of its FY2023 consolidated revenue. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Acquisition of Shares and Investment Certificates in Another Corporation (Voluntary Disclosure) / 2024-12-17

December 17, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion acquired 2,000,000 shares (KRW 10 billion) of its newly established Contract Development and Manufacturing Organization (CDMO) entity, ‘Celltrion BioSolutions,’ via cash contribution, securing a 100% equity stake as a wholly-owned subsidiary. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P13 SC (Zymfentra) in Europe (Part 1 & 2) (Rheumatoid Arthritis Patients) / 2024-12-17

December 17, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion received Phase 3 Clinical Trial Application (CTA) (Part 1 & Part 2) approval from the European Medicines Agency (EMA) for CT-P13 SC (Zymfentra), targeting patients with rheumatoid arthritis. 📊 Key Disclosure Content & Financial Highlights 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Monitoring Clinical Trial…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Electro-Mechanics (009150) – Setting of Record Date and Closure of Shareholder Register / 2024-12-16

December 16, 2024July 30, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Electro-Mechanics set December 31, 2024, as the record date and determined the closure of the shareholder register (suspension of entry of alteration) from January 1, 2025, to January 31, 2025, to designate entitled shareholders for the 52nd Annual General Meeting of Shareholders. 📊 [Summary of…

Semiconductors, Disclosures